Adaptimmune Therapeutics shares owned by Lindbrook Capital
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Lindbrook Capital
from 13F filings
Historical chart of Lindbrook Capital investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Lindbrook Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $908 | 4.6k | 0.20 |
| 2024-12-31 | $2.5k | 4.6k | 0.54 |
| 2024-09-30 | $4.6k | 4.8k | 0.95 |
| 2024-06-30 | $4.5k | 4.6k | 0.97 |
| 2024-03-31 | $11k | 6.7k | 1.58 |
| 2023-12-31 | $3.7k | 4.6k | 0.79 |
| 2023-09-30 | $3.6k | 4.6k | 0.78 |
| 2023-06-30 | $4.3k | 4.6k | 0.92 |
| 2022-09-30 | $3.0k | 3.1k | 0.97 |
| 2022-06-30 | $1.0k | 318 | 3.14 |
| 2022-03-31 | $0 | 179 | 0.00 |
| 2021-12-31 | $12k | 3.3k | 3.66 |
| 2021-09-30 | $45k | 8.7k | 5.19 |
| 2021-06-30 | $28k | 6.6k | 4.24 |
| 2021-03-31 | $9.0k | 1.6k | 5.59 |
| 2020-12-31 | $9.0k | 1.6k | 5.59 |
| 2020-09-30 | $13k | 1.6k | 8.07 |
| 2020-06-30 | $41k | 4.1k | 10.10 |
| 2020-03-31 | $3.0k | 938 | 3.20 |